American Peptide to expand manufacturing capacity at Vista

Published: 5-May-2010
Manufacturing Ingredients

Move will enable APC to process large-scale peptide production and meet cGMP standards

American Peptide Company (APC), a provider of peptides and peptide-based services to the pharmaceutical and biotech industries, is to ramp up its cGMP (current Good Manufacturing Practice) peptide manufacturing capabilities as well as its service offerings.

The expansion of its facility in Vista, California, US will allow APC to process large-scale peptide production needs while still meeting the high standards of GMP regulations.

The expansion will take place in three main areas of purification, synthesis and lyophilisation.

Four new peptide purification suites will be added for large-scale purification projects. The company also plans to build two new synthesis suites, both for solution phase and solid phase.

For the lyophilisation process, another capacity tray will be added to allow the release of multi-kg single batches of peptide APIs.

‘As the demand for peptide-based therapies increases, we are constantly seeking ways to enhance our operations to meet customer demands for large volumes without compromising our high standards for production,’ said Takahiro Ogata, chief operating officer of APC.

In addition to the expansion of its manufacturing capabilities, APC continues to offer the Total Peptide Management programme as a way of providing customers with increased regulatory support and value-added services. The programme offers a broad portfolio of peptides, and expert consultation to support customers as drug products move from discovery to development and commercialisation.

See more

You may also like

Ingredients

Bachem acquires American Peptide Company

Read more
No financial details have been disclosed

Trending Articles

  1. Lyocontract invests €50m in new freeze-drying facility with Syntegon vial line German CDMO Lyocontract has begun construction of a €50m expansion in Ilsenburg, partnering with Syntegon to install a complete vial filling and lyophilisation line for sterile freeze-dried pharmaceuticals
  2. Why weight sorting should move earlier in OSD development Phillip Ruda explains how earlier weight intelligence can improve process understanding, reduce risk and accelerate learning cycles
  3. Viatris to cut 10% of its global workforce after Indian plant fire Viatris has lowered its profit outlook for 2026 after a fire in February shut down a key plant in Nashik, India. Despite this, the company reported stronger-than-expected revenue and announced a restructuring plan
  4. You need to be a subscriber to read this article.
    Click here to find out more.
    Moving with speed and scale: innovative, material-sparing approaches to accelerate clinical development As early-stage drug development is often hindered by limited API supply, rising costs and tight timelines, material-sparing technologies are helping companies to progress faster with less
  5. Piramal Pharma Solutions’ Grangemouth facility successfully delivers 1500th ADC batch With this achievement, Piramal strengthens its leadership position in delivering critical bioconjugate therapies to patients in need

Upcoming event

DCAT Week

23–26 March 2026 | Conference | New York, US See all

You may also like

Ingredients

Bachem acquires American Peptide Company

No financial details have been disclosed
You need to be a subscriber to read this article.
Click here to find out more.
Ingredients

CPPs: beating drug delivery barriers

Cell-penetrating peptides are a promising tool for cellular import of drug cargos and have been applied in the delivery of a variety of therapeutic molecules. Jyothi Thundimadathil and Archana Gangakhedkar, American Peptide Co, highlight recent application studies
You need to be a subscriber to read this article.
Click here to find out more.
Ingredients

Bicyclic peptides for a new class of targeted drugs

Bicyclic peptides are an emerging class of molecules used to explore new cellular sites not treatable using small molecules or large antibodies. Archana Gangakhedkar, American Peptide Company, reveals some of the properties that offer a new route to targeting diseases
Manufacturing

Abzena named a leader in Frost & Sullivan ADC CDMO radar report

Recognition highlights integrated capabilities, proprietary technology and expertise in antibody-drug conjugates
Manufacturing

LabVantage Solutions introduces LabVantage CORTEX, advancing its LIMS platform for AI-driven laboratory operations

Next-Generation Platform Extends LIMS with Agentic AI and Cloud-Native Automation to Improve Efficiency, Reduce Errors and Gain Deeper Insight from Data. Learn More from LabVantage Leadership at Pittcon 2026
Manufacturing

Schütz to build automated IBC production facility at BASF's Ludwigshafen headquarters

Packaging specialist Schütz has signed an agreement with BASF to construct a highly automated intermediate bulk container manufacturing and storage facility directly adjacent to the chemical giant's main plant in Ludwigshafen, enabling round-the-clock just-in-time delivery
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

LGM Pharma announces $9 million investment into Colorado and Texas manufacturing facilities

The investment marks the second phase of the the company's expansion, funding facility upgrades to increase capacity for suppository, semi-solid and oral solid dose and differentiating LGM in the US CDMO market, says CEO Prasad Raje, speaking exclusively to Manufacturing Chemist
Subscribe now